PGY-3 Vik Induru joins Casey and Alex to discuss two recent non-inferiority trials questioning the necessity of prolonged IV antibiotic courses (vs oral antibiotics) for infective endocarditis (POET trial) and bone and joint infections (OVIVA). Stick around for a bonus discussion of the groundbreaking pre-print results of RECOVERY trial for the treatment of COVID-19!
Meet Peter Thorne, PGY-3 and future nephrologist, as he teaches us about the PREDESCI Study and the enlarging role of beta-blockade in clinically significant portal hypertension!
Join PGY-3 and upcoming chief resident Blake Funke in a discussion on the data behind post-cardiac arrest cooling in non-shockable rhythms. Learn about the fragility index, and why it matters!
Learn about C. diff, Wernicke's, and Leukostasis with Brian, Casey, and Alex. DISCLAIMER: This podcast is made by and for our internal medicine residents to enhance our educational experience. The content while edited by residents is not verified by host or speakers and we are not content experts on these topics. The content provided by this podcast is not intended and should not construe as medical advice, and should not be used to diagnose or treat any medical condition. We attempt to avoid use of opinion but all opinions represented are our own and not representative of our employer.
"The Q Files": The premier of our new episode format! Join our resident-led discussion on ground-breaking clinical trials and how they may change our practice. Up first is David Li, an aspiring nephrologist, with the CREDENCE trial and how SGLT-2 inhibitors are quickly becoming nephrologists' best friends.